Reports
Reports
The global umbilical cord blood banking market attained a value of USD 20.42 billion in 2020. The market is further expected to grow at a CAGR of 5.8% in the forecast period of 2024-2032 to reach a value of USD 27.07 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for umbilical cord blood banking is being driven by the rapid prevalence of chronic diseases, along with the rising demand for regenerative medicines. Moreover, several government associations and initiatives are contributing to the market growth for umbilical cord blood bank. Regionally, North America is the significant market for the product, followed by Europe and the Asia Pacific. In Europe, the umbilical cord blood banking industry is thriving owing to the rising awareness regarding the potential applications of cord blood to cure life-threatening diseases. Further, the rising number of live births is playing a significant role in the development of umbilical cord blood banking industry in Europe. Also, now the new born’s family, across Europe, donates as well as preserves cord blood in private or public banks as a result of the growing awareness about the potential of cord blood.
Umbilical cord blood or UCB is the blood collected from the umbilical cord of a new born baby. It is also retrieved from the placenta post-delivery. The UCB is enriched with adult stem cells, which play an important role in controlling all biological activities and in producing tissues in the human body. An umbilical cord blood bank is an alternative source of cells for the purpose of transplantation.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of storage operation, the market is divided into:
Based on service type, the industry can be segmented into:
By application, the industry is categorised into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for umbilical cord blood banking is being driven by the significant contribution by the North America region. Within North America, the United States is the largest market for umbilical cord blood banking, followed by Canada. The market is predominantly being dominated by the rising prevalence of chronic diseases. Furthermore, several government associations are taking initiatives to enhance the awareness regarding the significance of cord blood donation in the region.
The report gives a detailed analysis of the following key players in the global umbilical cord blood banking market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Storage Operation |
|
Breakup by Service Type |
|
Breakup by Application |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Umbilical Cord Blood Banking Market Overview
3.1 Global Umbilical Cord Blood Banking Market Historical Value (2017-2023)
3.2 Global Umbilical Cord Blood Banking Market Forecast Value (2024-2032)
4 Global Umbilical Cord Blood Banking Market Landscape
4.1 Global Umbilical Cord Blood Banking Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Umbilical Cord Blood Banking Product Landscape
4.2.1 Analysis by Storage Operation
4.2.2 Analysis by Service Type
4.2.3 Analysis by Application
5 Global Umbilical Cord Blood Banking Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Umbilical Cord Blood Banking Market Segmentation
6.1 Global Umbilical Cord Blood Banking Market by Storage Operation
6.1.1 Market Overview
6.1.2 Private UCB Bank
6.1.3 Public UCB Bank
6.2 Global Umbilical Cord Blood Banking Market by Service Type
6.2.1 Market Overview
6.2.2 Sample Preservation and Storage
6.2.3 Sample Analysis
6.2.4 Sample Processing
6.2.5 Sample Collection and Transportation
6.3 Global Umbilical Cord Blood Banking Market by Application
6.3.1 Market Overview
6.3.2 Bone Marrow Failure Syndrome
6.3.3 Metabolic Disorder
6.3.4 Leukaemia
6.3.5 Immune Deficiencies
6.3.6 Lymphoma
6.4 Global Umbilical Cord Blood Banking Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Umbilical Cord Blood Banking Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Umbilical Cord Blood Banking Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Umbilical Cord Blood Banking Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Umbilical Cord Blood Banking Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Umbilical Cord Blood Banking Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 CBR Systems, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Cryo-Cell International, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Smart Cells International Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Global Cord Blood Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Stemcyte India Therapeutics Pvt. Ltd
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Americord Registry LLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 China Cord Blood Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Cordlife Group LImited
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Esperite N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Lifeforce Cryobank Science Inc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Umbilical Cord Blood Banking Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2020, the global umbilical cord blood banking market attained a value of nearly USD 20.42 billion.
The market is projected to grow at a CAGR of 5.8% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 27.07 billion by 2026.
The major drivers of the industry, such as rising disposable incomes, rapid prevalence of chronic diseases, rising demand for regenerative medicines, rising number of live births, and extensive applications, are expected to aid the market growth.
The key trend guiding the growth of the market includes the rising number of favourable government initiatives.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading storage operations of umbilical cord blood banking in the market are private UCB banks and public UCB banks.
The major service types of umbilical cord blood banking in the industry are sample preservation and storage, sample analysis, sample processing, and sample collection and transportation.
The significant application segments in the market are bone marrow failure syndrome, metabolic disorder, leukaemia, immune deficiencies, and lymphoma.
The major players in the industry are CBR Systems, Inc., Cryo-Cell International, Inc., Smart Cells International Ltd., Global Cord Blood Corporation, and Stemcyte India Therapeutics Pvt. Ltd, among others.
The global umbilical cord blood banking market attained a value of USD 20.42 billion in 2020, driven by the rising prevalence of chronic diseases. Aided by the growing implementation of favourable government programmes, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 5.8%. The market is projected to reach USD 27.07 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on storage operation, the market is bifurcated into private UCB banks and public UCB banks. By service type, the industry is divided into sample preservation and storage, sample analysis, sample processing, and sample collection and transportation. On the basis of application, the market is segmented into bone marrow failure syndrome, metabolic disorder, leukaemia, immune deficiencies, and lymphoma. The major regional markets for umbilical cord blood banking are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include CBR Systems, Inc., Cryo-Cell International, Inc., Smart Cells International Ltd., Global Cord Blood Corporation, and Stemcyte India Therapeutics Pvt. Ltd, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.